FGFR1 and ductal breast carcinoma in situ: Furthermore, there have been few studies comparing amplification of FGFR1 in pure DCIS, DCIS associated with invasive cancer, and invasive breast cancer, although it has been found to be associated with breast cancer progression [14,16,17].